A Study Assessing Brain Activity, Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers

Clinical trial NCT07050368 · COMPLETED

Trial details

NCT number: NCT07050368
Sponsor: MycoMedica Life Sciences PBC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2025-07-28
Primary completion: 2026-01-13
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.